Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 20 of 20 entries
Sorted by: Best Match Show Resources per page
Design and application of a structured phantom for detection performance comparison between breast tomosynthesis and digital mammography.

Physics in medicine and biology

Cockmartin L, Marshall NW, Zhang G, Lemmens K, Shaheen E, Van Ongeval C, Fredenberg E, Dance DR, Salvagnini E, Michielsen K, Bosmans H.
PMID: 28072573
Phys Med Biol. 2017 Jan 10;62(3):758-780. doi: 10.1088/1361-6560/aa5407. Epub 2017 Jan 10.

This paper introduces and applies a structured phantom with inserted target objects for the comparison of detection performance of digital breast tomosynthesis (DBT) against 2D full field digital mammography (FFDM). The phantom consists of a 48 mm thick breast-shaped...

Cite
Cockmartin L, Marshall NW, Zhang G, et al. Design and application of a structured phantom for detection performance comparison between breast tomosynthesis and digital mammography. Phys Med Biol. 2017;62(3):758-780doi: 10.1088/1361-6560/aa5407.
Cockmartin, L., Marshall, N. W., Zhang, G., Lemmens, K., Shaheen, E., Van Ongeval, C., Fredenberg, E., Dance, D. R., Salvagnini, E., Michielsen, K., & Bosmans, H. (2017). Design and application of a structured phantom for detection performance comparison between breast tomosynthesis and digital mammography. Physics in medicine and biology, 62(3), 758-780. https://doi.org/10.1088/1361-6560/aa5407
Cockmartin, L, et al. "Design and application of a structured phantom for detection performance comparison between breast tomosynthesis and digital mammography." Physics in medicine and biology vol. 62,3 (2017): 758-780. doi: https://doi.org/10.1088/1361-6560/aa5407
Cockmartin L, Marshall NW, Zhang G, Lemmens K, Shaheen E, Van Ongeval C, Fredenberg E, Dance DR, Salvagnini E, Michielsen K, Bosmans H. Design and application of a structured phantom for detection performance comparison between breast tomosynthesis and digital mammography. Phys Med Biol. 2017 Jan 10;62(3):758-780. doi: 10.1088/1361-6560/aa5407. Epub 2017 Jan 10. PMID: 28072573.
Copy Download .nbib Format: NLM
Sclerosing Lymphocytic Lobulitis Mimicking a Tumor Relapse in a Young Woman with a History of Breast Cancer.

Journal of the Belgian Society of Radiology

Decraene J, Van Ongeval C, Clinckemaillie G, Wildiers H.
PMID: 30039071
J Belg Soc Radiol. 2015 Sep 15;99(1):72-75. doi: 10.5334/jbr-btr.835.

Sclerosing lymphocytic lobulitis or diabetic mastopathy is a benign entity with non-specific imaging features which can mimic breast carcinoma. It is a condition commonly associated with long standing diabetes and has also been linked with various auto-immune diseases. We...

Cite
Decraene J, Van Ongeval C, Clinckemaillie G, et al. Sclerosing Lymphocytic Lobulitis Mimicking a Tumor Relapse in a Young Woman with a History of Breast Cancer. J Belg Soc Radiol. 2015;99(1):72-75doi: 10.5334/jbr-btr.835.
Decraene, J., Van Ongeval, C., Clinckemaillie, G., & Wildiers, H. (2015). Sclerosing Lymphocytic Lobulitis Mimicking a Tumor Relapse in a Young Woman with a History of Breast Cancer. Journal of the Belgian Society of Radiology, 99(1), 72-75. https://doi.org/10.5334/jbr-btr.835
Decraene, J, et al. "Sclerosing Lymphocytic Lobulitis Mimicking a Tumor Relapse in a Young Woman with a History of Breast Cancer." Journal of the Belgian Society of Radiology vol. 99,1 (2015): 72-75. doi: https://doi.org/10.5334/jbr-btr.835
Decraene J, Van Ongeval C, Clinckemaillie G, Wildiers H. Sclerosing Lymphocytic Lobulitis Mimicking a Tumor Relapse in a Young Woman with a History of Breast Cancer. J Belg Soc Radiol. 2015 Sep 15;99(1):72-75. doi: 10.5334/jbr-btr.835. PMID: 30039071; PMCID: PMC6032652.
Copy Download .nbib Format: NLM
Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in .

Journal of oncology

Dullens B, de Putter R, Lambertini M, Toss A, Han S, Van Nieuwenhuysen E, Van Gorp T, Vanderstichele A, Van Ongeval C, Keupers M, Prevos R, Celis V, Dekervel J, Everaerts W, Wildiers H, Nevelsteen I, Neven P, Timmerman D, Smeets A, Denayer E, Van Buggenhout G, Legius E, Punie K.
PMID: 32655641
J Oncol. 2020 Jun 20;2020:9873954. doi: 10.1155/2020/9873954. eCollection 2020.

Germline pathogenic alterations in the breast cancer susceptibility genes 1 (

Cite
Dullens B, de Putter R, Lambertini M, et al. Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in . J Oncol. 2020;2020:9873954doi: 10.1155/2020/9873954.
Dullens, B., de Putter, R., Lambertini, M., Toss, A., Han, S., Van Nieuwenhuysen, E., Van Gorp, T., Vanderstichele, A., Van Ongeval, C., Keupers, M., Prevos, R., Celis, V., Dekervel, J., Everaerts, W., Wildiers, H., Nevelsteen, I., Neven, P., Timmerman, D., Smeets, A., Denayer, E., Van Buggenhout, G., Legius, E., & Punie, K. (2020). Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in . Journal of oncology, 20209873954. https://doi.org/10.1155/2020/9873954
Dullens, Boudewijn, et al. "Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in ." Journal of oncology vol. 2020 (2020): 9873954. doi: https://doi.org/10.1155/2020/9873954
Dullens B, de Putter R, Lambertini M, Toss A, Han S, Van Nieuwenhuysen E, Van Gorp T, Vanderstichele A, Van Ongeval C, Keupers M, Prevos R, Celis V, Dekervel J, Everaerts W, Wildiers H, Nevelsteen I, Neven P, Timmerman D, Smeets A, Denayer E, Van Buggenhout G, Legius E, Punie K. Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in . J Oncol. 2020 Jun 20;2020:9873954. doi: 10.1155/2020/9873954. eCollection 2020. PMID: 32655641; PMCID: PMC7322604.
Copy Download .nbib Format: NLM
Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review.

Insights into imaging

Swinnen J, Keupers M, Soens J, Lavens M, Postema S, Van Ongeval C.
PMID: 30411278
Insights Imaging. 2018 Dec;9(6):961-970. doi: 10.1007/s13244-018-0667-5. Epub 2018 Nov 08.

OBJECTIVES: The article summarises the available guidelines on breast imaging surveillance after curative treatment for locoregional breast cancer.METHODS: A systematic review of practice guidelines published from 1 January 2007 to 1 January 2017 was performed according to PRISMA methodology....

Cite
Swinnen J, Keupers M, Soens J, et al. Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review. Insights Imaging. 2018;9(6):961-970doi: 10.1007/s13244-018-0667-5.
Swinnen, J., Keupers, M., Soens, J., Lavens, M., Postema, S., & Van Ongeval, C. (2018). Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review. Insights into imaging, 9(6), 961-970. https://doi.org/10.1007/s13244-018-0667-5
Swinnen, Jeroen, et al. "Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review." Insights into imaging vol. 9,6 (2018): 961-970. doi: https://doi.org/10.1007/s13244-018-0667-5
Swinnen J, Keupers M, Soens J, Lavens M, Postema S, Van Ongeval C. Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review. Insights Imaging. 2018 Dec;9(6):961-970. doi: 10.1007/s13244-018-0667-5. Epub 2018 Nov 08. PMID: 30411278; PMCID: PMC6269345.
Copy Download .nbib Format: NLM
Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers.

European journal of radiology

Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C.
PMID: 34902667
Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26.

PURPOSE: Breast cancer gene (BRCA) 1 and 2 mutations are frequently studied gene mutations (GM); the incidence of checkpoint kinase 2 (CHEK2) is increasing. We describe the imaging features of breast cancer (BC) in CHEK2 mutations, compared to BRCA...

Cite
Ghunaim H, Laenen A, De Keyzer F, et al. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021;146:110074doi: 10.1016/j.ejrad.2021.110074.
Ghunaim, H., Laenen, A., De Keyzer, F., Soens, J., Keupers, M., Postema, S., Neven, P., & Van Ongeval, C. (2021). Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. European journal of radiology, 146110074. https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim, Hadeel, et al. "Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers." European journal of radiology vol. 146 (2021): 110074. doi: https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26. PMID: 34902667.
Copy Download .nbib Format: NLM
Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers.

European journal of radiology

Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C.
PMID: 34902667
Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26.

PURPOSE: Breast cancer gene (BRCA) 1 and 2 mutations are frequently studied gene mutations (GM); the incidence of checkpoint kinase 2 (CHEK2) is increasing. We describe the imaging features of breast cancer (BC) in CHEK2 mutations, compared to BRCA...

Cite
Ghunaim H, Laenen A, De Keyzer F, et al. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021;146:110074doi: 10.1016/j.ejrad.2021.110074.
Ghunaim, H., Laenen, A., De Keyzer, F., Soens, J., Keupers, M., Postema, S., Neven, P., & Van Ongeval, C. (2021). Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. European journal of radiology, 146110074. https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim, Hadeel, et al. "Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers." European journal of radiology vol. 146 (2021): 110074. doi: https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26. PMID: 34902667.
Copy Download .nbib Format: NLM
Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers.

European journal of radiology

Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C.
PMID: 34902667
Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26.

PURPOSE: Breast cancer gene (BRCA) 1 and 2 mutations are frequently studied gene mutations (GM); the incidence of checkpoint kinase 2 (CHEK2) is increasing. We describe the imaging features of breast cancer (BC) in CHEK2 mutations, compared to BRCA...

Cite
Ghunaim H, Laenen A, De Keyzer F, et al. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021;146:110074doi: 10.1016/j.ejrad.2021.110074.
Ghunaim, H., Laenen, A., De Keyzer, F., Soens, J., Keupers, M., Postema, S., Neven, P., & Van Ongeval, C. (2021). Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. European journal of radiology, 146110074. https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim, Hadeel, et al. "Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers." European journal of radiology vol. 146 (2021): 110074. doi: https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26. PMID: 34902667.
Copy Download .nbib Format: NLM
Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?.

SpringerPlus

Smeets A, Yoshihara E, Laenen A, Reynders A, Soens J, Wildiers H, Paridaens R, Van Ongeval C, Floris G, Neven P, Christiaens MR.
PMID: 23961380
Springerplus. 2013 Jun 23;2:275. doi: 10.1186/2193-1801-2-275. eCollection 2013.

Since the routine clinical use of the sentinel lymph node (SLN) procedure, questions have been raised concerning an increase in the overall percentage of node-positive patients. The goal of our study was to compare the sensitivity of the SLN...

Cite
Smeets A, Yoshihara E, Laenen A, et al. Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?. Springerplus. 2013;2:275doi: 10.1186/2193-1801-2-275.
Smeets, A., Yoshihara, E., Laenen, A., Reynders, A., Soens, J., Wildiers, H., Paridaens, R., Van Ongeval, C., Floris, G., Neven, P., & Christiaens, M. R. (2013). Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?. SpringerPlus, 2275. https://doi.org/10.1186/2193-1801-2-275
Smeets, Ann, et al. "Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?." SpringerPlus vol. 2 (2013): 275. doi: https://doi.org/10.1186/2193-1801-2-275
Smeets A, Yoshihara E, Laenen A, Reynders A, Soens J, Wildiers H, Paridaens R, Van Ongeval C, Floris G, Neven P, Christiaens MR. Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?. Springerplus. 2013 Jun 23;2:275. doi: 10.1186/2193-1801-2-275. eCollection 2013. PMID: 23961380; PMCID: PMC3699711.
Copy Download .nbib Format: NLM
Showing 13 to 20 of 20 entries